Company Analysis

Calidi Biotherapeutics, Inc. (CLDI)

NYSE: CLDI · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2021
Grade4.0
◀ Past 3.2● Present 2.4▶ Future 5.8
6 est.

Who runs Calidi Biotherapeutics, Inc.

The record holds no Form 3, 4 or 5 for this company yet, so no officer or director is named.
SI Assistanton CLDI · research, not advice